Organoids have revolutionized science and medicine, providing platforms for disease modeling, drug testing, and understanding ...

Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.

Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant ...

Hone Health reports that, when it comes to slowing aging and extending lifespan, few interventions are as well-supported by ...

Researchers at Stanford University have proposed a concept that could transform modern medicine: lab-grown human “bodyoids” ...

India’s Group Captain Shubhanshu Shukla will pilot the Axiom-4 mission to the ISS, involving around 60 scientific studies, ...

This involves, Ali explained promoting economic diversification and investing in high-value, technology-driven industries.

A new Drosophila collection of Parkinsonism models reveals early synaptic cholinergic projection neuron dysfunction, linking synaptic failure to later dopaminergic decline, highlighting a role for ...